ERBB2 and breast cancer: Mammary cancers are also classified into four subtypes according to the expression of immunohistochemical markers including estrogen receptor (ER), progesterone receptor (PR), and receptor of human epidermal growth factor 2 (HER-2 or EGFR-2): I. Luminal A (ER+ and/or PR+, and HER-2−), II.